Dr Paul Joseph Mccausland, MD, MPH in Haverford, PA - Preventive Medicine

Dr Paul Joseph Mccausland, MD, MPH is a Preventive Medicine - Preventive Medicine/occupational Environmental Medicine physician based in Haverford, Pennsylvania. Dr Paul Joseph Mccausland is licensed to practice in Pennsylvania (license number MD023736E) and his current practice location is 100 Quaker Ln, Haverford, Pennsylvania. He can be reached at his office (for appointments etc.) via phone at (610) 658-1966.

NPI number for Dr Paul Joseph Mccausland is 1730284506 and his current mailing address is 100 Quaker Ln, Haverford, Pennsylvania. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1730284506.

Contact Information

	Dr Paul Joseph Mccausland, MD, MPH
	100 Quaker Ln, Haverford, PA 19041-1034
	(610) 658-1966
	(610) 859-1100

Physician's Profile

Full Name	Dr Paul Joseph Mccausland
Gender	Male
Speciality	Preventive Medicine - Preventive Medicine/occupational Environmental Medicine
Location	100 Quaker Ln, Haverford, Pennsylvania
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1730284506
Provider Enumeration Date: 09/14/2006
Last Update Date: 05/19/2016

Medical Identifiers

Medical identifiers for Dr Paul Joseph Mccausland such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1730284506	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Q00000X	Family Medicine	MD0237364E (Pennsylvania)	Secondary
2083P0500X	Preventive Medicine - Preventive Medicine/occupational Environmental Medicine	MD023736E (Pennsylvania)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Paul Joseph Mccausland is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Paul Joseph Mccausland, MD, MPH 100 Quaker Ln, Haverford, PA 19041-1034 Ph: (610) 658-1966	Dr Paul Joseph Mccausland, MD, MPH 100 Quaker Ln, Haverford, PA 19041-1034 Ph: (610) 658-1966

News Archive

Women riders support MDA's initiative on neuromuscular disease

During this year's 69th Annual Daytona Bike Week, hundreds of female motorcycle enthusiasts and Harley-Davidson Motor Company are banding together to support the Muscular Dystrophy Association (MDA) and their efforts to find a cure for neuromuscular disease.

AF patients at risk for stroke mostly treated with aspirin-only prescription instead of blood thinners

Researchers at University of California San Diego School of Medicine and University of California, San Francisco School of Medicine report that more than 1 in 3 atrial fibrillation (AF) patients at intermediate to high risk for stroke are treated with aspirin alone, despite previous data showing this therapy to be inferior to blood thinners.

Loyola medical students and CRJHS students team up to promote healthcare awareness

Loyola University Chicago Stritch School of Medicine and Marcella Niehoff School of Nursing students are teaming up with high schoolers from Cristo Rey Jesuit High School (CRJHS) to bring awareness and share ideas about health care now and in the future.

Study could lead towards a personalised medicine for chemoresistant lymphomata

To date, tests have only been carried out on cells, but a piece of research conducted by the Department of Genetics at the UPV/EHU's Faculty of Medicine in collaboration with MD Anderson and the CNIO is opening up the door for the treatment of lymphoma types that have a lower survival rate. The study of the molecular characteristics of the tumours would enable molecules that are altered in a specific way to be identified and turned into new therapeutic targets that would improve the prognosis of patients with chemoresistant lymphomata.

Lung cancer cells activate inflammation to induce metastasis

A research team from the University of California, San Diego School of Medicine has identified a protein produced by cancerous lung epithelial cells that enhances metastasis by stimulating the activity of inflammatory cells.

Dr Paul Joseph Mccausland, MD, MPH - Preventive Medicine in Haverford, PA